JNJ Biotech Wednesday, November 4, 2026 -0.30 Negative

Reported Earlier: 'J&J's trispecific, Tibsovo's AML Win And Calquence's CLL Letdown As First ASH Abstracts Land' - Endpoints News

Reported Earlier: 'J&J's trispecific, Tibsovo's AML Win And Calquence's CLL Letdown As First ASH Abstracts Land' - Endpoints News

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed